14-Jun-2019 | Zion Market Research
Zion Market Research has published a new report titled “Apoptosis Assays Market by Product (Assay Kit, Reagent, Instruments, and Microplates), By Detection Technology (Flow Cytometry, Fluorescence Microscopy, and Others), By Application (Drug Discovery and Development, Clinical Research, Stem Cell Research, and Basic Research), and by End-User (Pharmaceutical and Biotechnology Companies, Diagnostic Labs, Hospitals, and Academic and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global apoptosis assays market was approximately USD 3.57 billion in 2018 and is expected to generate around USD 6.96 billion by 2025, at a CAGR of around 10% between 2019 and 2025.
Apoptosis assays, in simple words, are programmed cell deaths that genetically control cell ablation during their normal development process. This is used to eliminate old, unnecessary, and unhealthy cells without releasing any harmful substances into the nearby areas. The rising prevalence and incidences of various infectious and chronic diseases, growing funding for research related to cancer, and rising cell-based research are likely to drive the global apoptosis assays market development. Moreover, on-going developments related to apoptosis-modulating drugs are expected to further propel the growth of the global apoptosis assays market over the forecast time period. However, high capital investments and expensive detection technology may restrain the growth of the apoptosis assays market.
Browse the full “Apoptosis Assays Market by Product (Assay Kit, Reagent, Instruments, and Microplates), By Detection Technology (Flow Cytometry, Fluorescence Microscopy, and Others), By Application (Drug Discovery and Development, Clinical Research, Stem Cell Research, and Basic Research), and by End-User (Pharmaceutical and Biotechnology Companies, Diagnostic Labs, Hospitals, and Academic and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/apoptosis-assays-market
The global apoptosis assays market is segmented on the basis of product, detection technology, application, and end-user. By product, the market includes assay kit, reagent, instruments, and microplates. The assay kit segment held the largest market share in 2018, due to the repeated use of assay kit in various apoptosis testing processes and its growing use in biopharmaceutical production processes and screening of potential drugs.
Based on detection technology, the market is segmented into flow cytometry, fluorescence microscopy, and others. Due to the increasing adoption of cell imaging and microscopy, the flow cytometry segment contributed the largest share to the market in 2018, owing to the increasing adoption of cell imaging and microscopy.
By application, this global market is categorized into drug discovery and development, clinical research, stem cell research, and basic research. The drug discovery and development segment held the largest market share in 2018, due to the rising incidences of chronic and infectious diseases.
By end-user, the apoptosis assays market includes pharmaceutical and biotechnology companies, diagnostic labs, hospitals, and academic and research institutes. Pharmaceutical and biotechnological companies held a major market share in 2018, due to the increasing opportunities in R&D activities.
North America dominated the global apoptosis assays market in 2018, due to the large number of scientific studies being conducted across the region, growing chronic and infectious diseases prevalence, increasing support of government bodies in the form of research investments, and the availability of high-quality infrastructure for R&D. Europe held the second spot in the global apoptosis assays market, due to the increasing cases of cancer, cardiovascular diseases, and degenerative disorders. The Asia Pacific apoptosis assays market is among the emerging markets for apoptosis assays due to the increasing number of research and development facilities in the region, growing investments in the infrastructural sector, and rising number of clinical trial drug studies.
Some key players of the global apoptosis assays market include Merck KGaA, Thermo Fischer Scientific, Bio-Rad Laboratories, GE Healthcare, Geno Technology, BioTek Instruments, Biotium, Abcam, Canvax, Abnova, Creative Bioarray, Sartorius, Promega Corporation, PerkinElmer, and Danaher Corporation.
This report segments the global apoptosis assays market into:
Global Apoptosis Assays Market: By Product
Global Apoptosis Assays Market: By Detection Technology
Global Apoptosis Assays Market: By Application
Global Apoptosis Assays Market: By End-User
Global Apoptosis Assays Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651